BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 2010
View Archived Issues
Prophylactic, not therapeutic, CCR2 inhibition efficacious in choroidal neovascularization
Read More
Roflumilast reduces body weight and BMI in COPD and type 2 diabetes
Read More
Potent anti-inflammatory and immunosuppressive activity of DTCM-G supported by preclinical data
Read More
ML-3403 shows promise in mouse models of colitis and RA
Read More
DHMEQ improves colonic injury in experimental colitis
Read More
ABCB5 promising as new biomarker in retinoblastoma
Read More
Preclinical and clinical data presented on bronchodilator LAS-100977
Read More
Abbott discloses new cannabinoid CB2 receptor ligands
Read More
U.S. military researchers claim new antimalarial agents
Read More
Merck & Co. presents new somatostatin receptor sst3 antagonists
Read More
Sinapis Pharma secures financing for phase I methamphetamine trial
Read More
Optimer and Biocon sign manufacturing and supply agreement for fidaxomicin
Read More
Cellceutix signs agreements for Kevetrin phase I support
Read More
Sanofi-aventis and MIT's Center for Biomedical Innovation form strategic alliance
Read More
Valeant Pharmaceuticals finalizes acquisition of Aton Pharma
Read More
AcelRx reports on phase II trial of ARX-02 Sufentanil NanoTab
Read More
NormOxys begins phase I trial of allosteric hemoglobin effector OXY-111A
Read More
Patupilone does not meet primary endpoint in phase III trial in ovarian cancer
Read More
Galderma discloses new melanocortin MC1 receptor ligands
Read More
Cytokinetics opens phase IIa CK-2017357 trial in peripheral artery disease
Read More
Cethromycin shows preclinical efficacy against Plasmodium species
Read More
FDA clears Simplexa influenza A H1N1 (2009) test
Read More
Enrollment initiated in new phase III program of Lu-AA-21004 in MDD
Read More
New phase II trial to evaluate Reolysin plus gemcitabine in pancreatic cancer
Read More
FDA accepts filing of Horizon Pharma's NDA for Duexa
Read More